Company profile
The Joint Corp.
NASDAQ: JYNT · Healthcare · Medical - Care Facilities
#420 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
75B+FH 79DQ 76GM 67SS 65
v0.1 · 65/100 weight · provisional
↑ Piotroski F, return on equity · ↓ growth stability, balance-sheet leverage
Methodology →Revenue TTM
$56.6M
Rev growth YoY (TTM)
+221.8%
Net income (FY)
$2.9M
Employees
330
as of 2026-08-14
Market cap
$120.0M
as of 2026-08-14
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$54.9M$54.9M2025
Net income$2.9M$2.9M2025
Operating income-$913.4k-$913.4k2025
Total assets$61.0M$61.0M2025
Liabilities$45.9M$45.9M2025
Equity$15.1M$15.1M2025
Revenue trend
FY2024 – FY2025 · USD
FY24
FY24
FY24
FY24
FY25
FY25
FY25
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Royalty60%
Advertising19%
Technology Service11%
Franchise6%
Product and Service, Other3%
By geography
Not disclosed.
The read
What is The Joint Corp.’s revenue?
The Joint Corp. booked $54.9M in FY2025 revenue, growing 310% year over year — faster than 92% of Healthcare companies we track, at a 5.3% net margin.
Peers · Healthcare
HLS Therapeutics Inc.64C908 Devices Inc.60CNektar Therapeutics50DIntegrated BioPharma, Inc.67BAgios Pharmaceuticals, Inc.70BQ32 Bio Inc.72BNeighbors
Maricopa →Key facts
CEOSanjiv Razdan
SectorHealthcare
IndustryMedical - Care Facilities
HeadquartersScottsdale, AZ
ExchangeNASDAQ: JYNT
Employees330
IPO date2014-11-11
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.